- Home
- SHFS vs DRRX Comparison
SHFS vs DRRX Comparison
Compare SHFS & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHFS
- DRRX
- Stock Information
- Founded
- SHFS 2015
- DRRX 1998
- Country
- SHFS United States
- DRRX United States
- Employees
- SHFS N/A
- DRRX N/A
- Industry
- SHFS Finance: Consumer Services
- DRRX Biotechnology: Pharmaceutical Preparations
- Sector
- SHFS Finance
- DRRX Health Care
- Exchange
- SHFS Nasdaq
- DRRX Nasdaq
- Market Cap
- SHFS 35.0M
- DRRX 39.1M
- IPO Year
- SHFS N/A
- DRRX 2000
- Fundamental
- Price
- SHFS $0.59
- DRRX $1.57
- Analyst Decision
- SHFS
- DRRX Hold
- Analyst Count
- SHFS 0
- DRRX 3
- Target Price
- SHFS N/A
- DRRX $5.00
- AVG Volume (30 Days)
- SHFS 39.9K
- DRRX 64.4K
- Earning Date
- SHFS 08-14-2024
- DRRX 08-13-2024
- Dividend Yield
- SHFS N/A
- DRRX N/A
- EPS Growth
- SHFS N/A
- DRRX N/A
- EPS
- SHFS 0.08
- DRRX N/A
- Revenue
- SHFS $16,719,536.00
- DRRX $8,411,000.00
- Revenue This Year
- SHFS N/A
- DRRX N/A
- Revenue Next Year
- SHFS N/A
- DRRX $6.35
- P/E Ratio
- SHFS $6.98
- DRRX N/A
- Revenue Growth
- SHFS 34.73
- DRRX N/A
- 52 Week Low
- SHFS $0.41
- DRRX $0.47
- 52 Week High
- SHFS $1.55
- DRRX $3.14
- Technical
- Relative Strength Index (RSI)
- SHFS 45.96
- DRRX 58.82
- Support Level
- SHFS $0.55
- DRRX $1.37
- Resistance Level
- SHFS $0.65
- DRRX $1.66
- Average True Range (ATR)
- SHFS 0.05
- DRRX 0.09
- MACD
- SHFS -0.01
- DRRX 0.03
- Stochastic Oscillator
- SHFS 40.00
- DRRX 83.33
About SHFS SHF Holdings Inc.
SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring among others.
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .